494
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

, , , &
Pages 745-752 | Received 04 Oct 2015, Accepted 11 Dec 2015, Published online: 18 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Einar S. Björnsson. (2017) Primary sclerosing cholangitis: best practices for diagnosis. Expert Opinion on Orphan Drugs 5:9, pages 701-706.
Read now

Articles from other publishers (28)

Muhammad Salman Faisal, Humberto C. Gonzalez & Stuart C. Gordon. (2024) Primary Biliary Cholangitis. Clinics in Liver Disease 28:1, pages 63-77.
Crossref
Suman Acharya, Suraj Shrestha, Elisha Poddar, Ashru Neupane, Ramesh Khadayat, Sagar Rana Magar, Manoj Lamsal & Rahul Pathak. (2023) Antimitochondrial antibody (AMA) negative primary biliary cirrhosis with secondary sjogren syndrome: A case report. Annals of Medicine & Surgery.
Crossref
Francesco Martini, Daniele Balducci, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, Antonio Benedetti, Marco Marzioni & Luca Maroni. (2023) Risk Stratification in Primary Biliary Cholangitis. Journal of Clinical Medicine 12:17, pages 5713.
Crossref
Eirini I Rigopoulou & Dimitrios P Bogdanos. (2023) Role of autoantibodies in the clinical management of primary biliary cholangitis. World Journal of Gastroenterology 29:12, pages 1795-1810.
Crossref
Rami Al-Handola, Justine Chinnappan, Murtaza Hussain, Abdullahi Mahgoub & Ghassan Bachuwa. (2023) Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective Diagnosis. Cureus.
Crossref
Kristel K. Leung & Gideon M. Hirschfield. (2022) Autoantibodies in Primary Biliary Cholangitis. Clinics in Liver Disease 26:4, pages 613-627.
Crossref
Guilherme Grossi Lopes Cançado, Michelle Harriz Braga, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Mateus Jorge Nardelli, Luciana Costa Faria, Nathalia Mota de Faria Gomes, Elze Maria Gomes Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone Muniz Carvalho Fernandes da Cunha, Marlone Cunha-Silva, Liliana Sampaio Costa Mendes, Claudia Alexandra Pontes Ivantes, Liana Codes, Valéria Ferreira de Almeida e Borges, Fabio Heleno de Lima Pace, Mario Guimarães Pessoa, Izabelle Venturini Signorelli, Gabriela Perdomo Coral, Paulo Lisboa Bittencourt, Cynthia Levy & Cláudia Alves Couto. (2021) Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis. Digestive Diseases and Sciences 67:7, pages 3305-3312.
Crossref
Binu V. John, Bassam Dahman, Yangyang Deng, Nidah S. Khakoo, Tamar H. Taddei, David E. Kaplan & Cynthia Levy. (2021) Rates of decompensation, hepatocellular carcinoma and mortality in AMA‐negative primary biliary cholangitis cirrhosis. Liver International 42:2, pages 384-393.
Crossref
Hong You, Xiong Ma, Cumali Efe, Guiqiang Wang, Sook-Hyang Jeong, Kazumichi Abe, Weijia Duan, Sha Chen, Yuanyuan Kong, Dong Zhang, Lai Wei, Fu-Sheng Wang, Han-Chieh Lin, Jin Mo Yang, Tawesak Tanwandee, Rino A. Gani, Diana A. Payawal, Barjesh C. Sharma, Jinlin Hou, Osamu Yokosuka, A. Kadir Dokmeci, Darrell Crawford, Jia-Horng Kao, Teerha Piratvisuth, Dong Jin Suh, Laurentius A. Lesmana, Jose Sollano, George Lau, Shiv K. Sarin, Masao Omata, Atsushi Tanaka & Jidong Jia. (2022) APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatology International 16:1, pages 1-23.
Crossref
Francesca Colapietro, Ana Lleo & Elena Generali. (2021) Antimitochondrial Antibodies: from Bench to Bedside. Clinical Reviews in Allergy & Immunology 63:2, pages 166-177.
Crossref
Binu V. John, Kaley Schwartz, Cynthia Levy, Bassam Dahman, Yangyang Deng, Paul Martin, Tamar H. Taddei & David E. Kaplan. (2021) Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis. Hepatology Communications 5:8, pages 1426-1436.
Crossref
Valentina Guatibonza-García, Paula Valentina Gaete, Agustín Pérez-Londoño, Danna Kathalina Puerto-Baracaldo, Sebastián Antonio Gutiérrez-Romero, Carlos O Mendivil & Monica Tapias. (2021) Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study. World Journal of Gastroenterology 27:29, pages 4890-4899.
Crossref
Urszula Wasik, Agnieszka Kempinska-Podhorodecka, Dimitrios P. Bogdanos, Piotr Milkiewicz & Malgorzata Milkiewicz. (2020) Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis. Molecular Medicine 26:1.
Crossref
Lina Feng, Kaihui Dong, Xiaoxue Zhang, Bo Ma, Lin Chen, Qianqian Yang, Qingling Chen, Xiaoyu Wen & Qinglong Jin. (2020) Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China. PLOS ONE 15:11, pages e0242164.
Crossref
Jian-Dan Qian, Tian-Tian Yao, Yan Wang & Gui-Qiang Wang. (2020) Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators. Clinics and Research in Hepatology and Gastroenterology 44:6, pages 874-884.
Crossref
Tian-Tian Yao, Jian-Dan Qian & Gui-Qiang Wang. (2020) Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis. Medicina Clínica 155:4, pages 165-170.
Crossref
Tian-Tian Yao, Jian-Dan Qian & Gui-Qiang Wang. (2020) Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis. Medicina Clínica (English Edition) 155:4, pages 165-170.
Crossref
David Maxwell Hunter Chascsa & Keith Douglas Lindor. (2020) Emerging therapies for PBC. Journal of Gastroenterology 55:3, pages 261-272.
Crossref
Atsushi Tanaka & M. Eric Gershwin. 2020. The Autoimmune Diseases. The Autoimmune Diseases 1149 1171 .
Amika Moro, Keita Okubo & Kazunari Sasaki. (2019) Goodbye for Good: Stepping Away From Recurrence. Gastroenterology 156:8, pages 2353-2354.
Crossref
Paulina K. Phillips & Adnan Said. 2019. Gastrointestinal and Liver Disorders in Women’s Health. Gastrointestinal and Liver Disorders in Women’s Health 109 124 .
Keith D. Lindor, Christopher L. Bowlus, James Boyer, Cynthia Levy & Marlyn Mayo. (2018) Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology 69:1, pages 394-419.
Crossref
David M. Chascsa & Keith D. Lindor. (2018) Antimitochondrial Antibody–Negative Primary Biliary Cholangitis. Clinics in Liver Disease 22:3, pages 589-601.
Crossref
David E. J. Jones. 2018. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System 328 340 .
Chui-Wen Deng, Li Wang, Yun-Yun Fei, Chao-Jun Hu, Yun-Jiao Yang, Lin-Yi Peng, Xiao-Feng Zeng, Feng-Chun Zhang & Yong-Zhe Li. (2017) Exploring pathogenesis of primary biliary cholangitis by proteomics: A pilot study. World Journal of Gastroenterology 23:48, pages 8489-8499.
Crossref
Cynthia Levy, Andres F. Carrion & Marlyn J. Mayo. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver 523 545 .
Xiaoli Fan, Tingting Wang, Yi Shen, Xiaotan Xi & Li Yang. (2017) Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patients. Scientific Reports 7:1.
Crossref
Ying-Qiu Huang. (2016) Recent advances in the diagnosis and treatment of primary biliary cholangitis. World Journal of Hepatology 8:33, pages 1419.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.